Milosz Faber

1.9k total citations
27 papers, 1.4k citations indexed

About

Milosz Faber is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Milosz Faber has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 17 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Milosz Faber's work include Rabies epidemiology and control (26 papers), Viral Infections and Outbreaks Research (16 papers) and Virology and Viral Diseases (13 papers). Milosz Faber is often cited by papers focused on Rabies epidemiology and control (26 papers), Viral Infections and Outbreaks Research (16 papers) and Virology and Viral Diseases (13 papers). Milosz Faber collaborates with scholars based in United States, Germany and France. Milosz Faber's co-authors include Bernhard Dietzschold, Matthias J. Schnell, D. Craig Hooper, Rojjanaporn Pulmanausahakul, James P. McGettigan, Jianwei Li, Jianwei Li, Marie-Luise Faber, Eberhard Weihe and Sergei Spitsin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Milosz Faber

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milosz Faber United States	22	1.2k	640	631	348	209	27	1.4k
Xianfu Wu United States	19	691 0.6×	370 0.6×	299 0.5×	266 0.8×	166 0.8×	40	859
Rojjanaporn Pulmanausahakul Thailand	13	441 0.4×	305 0.5×	452 0.7×	126 0.4×	127 0.6×	19	886
D L Lodmell United States	25	806 0.7×	615 1.0×	427 0.7×	170 0.5×	270 1.3×	48	1.4k
T. J. Wiktor United States	15	900 0.8×	582 0.9×	454 0.7×	230 0.7×	310 1.5×	25	1.4k
Philippe Souque France	18	508 0.4×	278 0.4×	459 0.7×	105 0.3×	249 1.2×	30	1.2k
Roderick I. Macfarlan Australia	13	575 0.5×	404 0.6×	220 0.3×	125 0.4×	204 1.0×	17	947
N.J. Watt United Kingdom	18	498 0.4×	745 1.2×	177 0.3×	69 0.2×	331 1.6×	58	1.2k
Luciana Sarmento United States	15	287 0.2×	569 0.9×	434 0.7×	49 0.1×	94 0.4×	20	893
Aurore Vidy France	9	395 0.3×	273 0.4×	397 0.6×	37 0.1×	104 0.5×	14	813
Charles V. Trimarchi United States	14	475 0.4×	181 0.3×	151 0.2×	187 0.5×	179 0.9×	28	574

Countries citing papers authored by Milosz Faber

Since Specialization

Citations

This map shows the geographic impact of Milosz Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milosz Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milosz Faber more than expected).

Fields of papers citing papers by Milosz Faber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milosz Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milosz Faber. The network helps show where Milosz Faber may publish in the future.

Co-authorship network of co-authors of Milosz Faber

This figure shows the co-authorship network connecting the top 25 collaborators of Milosz Faber. A scholar is included among the top collaborators of Milosz Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milosz Faber. Milosz Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gnanadurai, Clement W., Yang Yang, Ying Huang, et al.. (2015). Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs. PLoS neglected tropical diseases. 9(8). e0004023–e0004023. 21 indexed citations

Schutsky, Keith, Carla Portocarrero, D. Craig Hooper, Bernhard Dietzschold, & Milosz Faber. (2014). Limited Brain Metabolism Changes Differentiate between the Progression and Clearance of Rabies Virus. PLoS ONE. 9(4). e87180–e87180. 17 indexed citations

Faber, Milosz, et al.. (2014). Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ. Virology. 474. 174–180. 12 indexed citations

Morin‐Brureau, Mélanie, et al.. (2013). A novel rabies virus-based glioma immunotherapeutic strategy targeting survivin (P4440). The Journal of Immunology. 190(Supplement_1). 126.5–126.5. 2 indexed citations

Schutsky, Keith, et al.. (2012). Intramuscular Inoculation of Mice with the Live-Attenuated Recombinant Rabies Virus TriGAS Results in a Transient Infection of the Draining Lymph Nodes and a Robust, Long-Lasting Protective Immune Response against Rabies. Journal of Virology. 87(3). 1834–1841. 25 indexed citations

Li, Jianwei, Adam Ertel, Carla Portocarrero, et al.. (2012). Postexposure Treatment with the Live-Attenuated Rabies Virus (RV) Vaccine TriGAS Triggers the Clearance of Wild-Type RV from the Central Nervous System (CNS) through the Rapid Induction of Genes Relevant to Adaptive Immunity in CNS Tissues. Journal of Virology. 86(6). 3200–3210. 44 indexed citations

Li, Jianwei, Milosz Faber, Bernhard Dietzschold, & D. Craig Hooper. (2011). The Role of Toll-Like Receptors in the Induction of Immune Responses During Rabies Virus Infection. Advances in virus research. 79. 115–126. 29 indexed citations

Faber, Milosz, et al.. (2009). Immunogenicity and Safety of Recombinant Rabies Viruses Used for Oral Vaccination of Stray Dogs and Wildlife. Zoonoses and Public Health. 56(6-7). 262–269. 41 indexed citations

Weihe, Eberhard, Michael Bette, Milosz Faber, et al.. (2008). Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies.. PubMed. 131. 73–81. 8 indexed citations

10.

Li, Jianwei, James P. McGettigan, Milosz Faber, Matthias J. Schnell, & Bernhard Dietzschold. (2007). Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway. Vaccine. 26(3). 419–426. 38 indexed citations

11.

Li, Jianwei, Milosz Faber, Amy B. Papaneri, et al.. (2006). A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology. 356(1-2). 147–154. 37 indexed citations

12.

Faber, Milosz, Michael Bette, Rojjanaporn Pulmanausahakul, et al.. (2005). Overexpression of Tumor Necrosis Factor Alpha by a Recombinant Rabies Virus Attenuates Replication in Neurons and Prevents Lethal Infection in Mice. Journal of Virology. 79(24). 15405–15416. 40 indexed citations

13.

Faber, Milosz, Elaine W. Lamirande, Anjeanette Roberts, et al.. (2005). A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. Journal of General Virology. 86(5). 1435–1440. 71 indexed citations

14.

Faber, Milosz, Marie-Luise Faber, Amy B. Papaneri, et al.. (2005). A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity. Journal of Virology. 79(22). 14141–14148. 152 indexed citations

15.

Marissen, Wilfred E., R. Arjen Kramer, Amy B. Rice, et al.. (2005). Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis. Journal of Virology. 79(8). 4672–4678. 72 indexed citations

16.

Prosniak, Mikhail, Milosz Faber, Cathleen A. Hanlon, et al.. (2003). Development of a Cocktail of Recombinant‐Expressed Human Rabies Virus–Neutralizing Monoclonal Antibodies for Postexposure Prophylaxis of Rabies. The Journal of Infectious Diseases. 188(1). 53–56. 69 indexed citations

17.

Dietzschold, Bernhard, Milosz Faber, & Matthias J. Schnell. (2003). New approaches to the prevention and eradication of rabies. Expert Review of Vaccines. 2(3). 399–406. 43 indexed citations

18.

Faber, Milosz, Rojjanaporn Pulmanausahakul, Sergei Spitsin, et al.. (2002). Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response. Journal of Virology. 76(7). 3374–3381. 168 indexed citations

19.

Pulmanausahakul, Rojjanaporn, Milosz Faber, Kinjiro Morimoto, et al.. (2001). Overexpression of Cytochromecby a Recombinant Rabies Virus Attenuates Pathogenicity and Enhances Antiviral Immunity. Journal of Virology. 75(22). 10800–10807. 51 indexed citations

20.

Morimoto, Kanehisa, Matthias J. Schnell, Rojjanaporn Pulmanausahakul, et al.. (2001). High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector. Journal of Immunological Methods. 252(1-2). 199–206. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact